TB-500 5mg
TB-500 5mg
Thymosin Beta-4 — powerful healing peptide. Accelerates tissue repair, reduces inflammation, and promotes angiogenesis.
Save 10% when you pay in crypto (BTC · ETH · USDT)
Free shipping on orders over $250
Research use only. Products are not intended for human consumption.
We accept
Interac e-Transfer · BTC · ETH · USDT crypto −10%
How ordering works
- 01Place your order — no payment is taken on this site.
- 02Payment instructions arrive by email reply (Interac e-Transfer or crypto).
- 03Paid before 4 PM EST → same-day dispatch with tracking number.
Refrigerated SKU? Ships in an insulated cold-pack mailer. You receive a packaging photograph within 4 hours of dispatch.
- Janoshik verified — per-batch third-party purity testing
- Discreet — plain packaging, no brand markings
- Cold-pack mailer for refrigerated SKUs
- Refund + retest if a batch fails purity
Complete protocols
Build your stack
Stacks that include TB-500 5mg — protocol components priced together, bulk savings applied automatically.
At a glance
At a glance
- Concentration
- 5mg
- Purity
- 99.5%+
- Route
- Subcutaneous injection
- Storage
- Lyophilized: room temperature, desiccated. Reconstituted: 2–8°C, ≤30 days.
Compound profile
TB-500 is a synthetic version of Thymosin Beta-4, a 43-amino-acid protein originally isolated from the thymus gland. Thymosin Beta-4 is one of the most abundant intracellular proteins and is expressed in virtually every tissue type, with particularly high concentrations in wound fluid, platelets, and cells undergoing migration. TB-500 replicates the active region of the full-length protein — specifically the actin-binding domain responsible for its regenerative properties — making it the research-optimized fragment of a naturally ubiquitous healing molecule.
TB-500 is a synthetic version of Thymosin Beta-4, a 43-amino-acid protein originally isolated from the thymus gland. Thymosin Beta-4 is one of the most abundant intracellular proteins and is expressed in virtually every tissue type, with particularly high concentrations in wound fluid, platelets, and cells undergoing migration. TB-500 replicates the active region of the full-length protein — specifically the actin-binding domain responsible for its regenerative properties — making it the research-optimized fragment of a naturally ubiquitous healing molecule.
TB-500 functions primarily through its interaction with actin, the structural protein that forms the cytoskeleton of every cell. By sequestering G-actin monomers and promoting their polymerization into F-actin filaments, TB-500 directly facilitates cell migration — the physical movement of cells into damaged tissue. This is the foundational mechanism of wound repair. Beyond cytoskeletal modulation, TB-500 promotes angiogenesis (new blood vessel formation) by upregulating vascular endothelial growth factor (VEGF), reduces inflammation through downregulation of pro-inflammatory cytokines including IL-1beta, TNF-alpha, and IL-6, and has demonstrated anti-fibrotic properties that may reduce scar tissue formation.
The research literature positions TB-500 as a systemic tissue repair agent. Unlike BPC-157, which acts preferentially at local injection sites, TB-500 distributes throughout the body after administration and exerts effects wherever tissue damage or inflammation exists. Studies have demonstrated accelerated healing in cardiac tissue following ischemic injury, improved dermal wound closure rates, reduced inflammation in musculoskeletal injuries, and enhanced recovery of damaged neural tissue. Researchers have also noted improvements in hair regrowth models, suggesting effects on dermal stem cell populations.
TB-500 is best suited for researchers investigating systemic recovery from musculoskeletal injuries, post-surgical healing, chronic inflammatory conditions, and cardiac tissue repair. It is the preferred companion to BPC-157 in healing stacks: TB-500 provides the broad, systemic regenerative signal while BPC-157 concentrates healing activity at the local level. This pairing is one of the most widely referenced combinations in the peptide research community.
Each 5mg vial should be reconstituted with 1-2ml bacteriostatic water. TB-500 has a notably long half-life of approximately 14 days, which allows for less frequent dosing compared to most peptides — typically twice-weekly subcutaneous injection. Researchers commonly use a loading phase of 5-10mg per week for the first 4-6 weeks, followed by a maintenance phase of 2-5mg per week. Reconstituted solution should be stored at 2-8C. TB-500 can be injected subcutaneously at any site; its systemic distribution means injection location is less critical than with site-specific compounds.
How to use
Injection technique, site rotation, and frequency guidance. Typical protocols split the weekly dose into 2 injections.
TB-500 5mg is supplied as a lyophilized (freeze-dried) powder and must be reconstituted with bacteriostatic water (BAC water) before use in a research setting.
- Clean the BAC water vial stopper and the peptide vial stopper with an alcohol swab. Allow to dry.
- Draw the required volume of BAC water into a sterile syringe (typically 1–3 mL depending on target concentration).
- Angle the needle so the water runs down the inside wall of the peptide vial. Avoid dispensing directly onto the powder.
- Do not shake. Gently swirl or roll until fully dissolved. Vigorous shaking can denature peptides.
- Refrigerate reconstituted solution at 2–8°C. Most reconstituted peptides are stable 14–30 days depending on compound.
Target concentration determines drawing volume. For dosing math, consult the dosing math guide.
Independent lab verification
Research disclaimer
For research and laboratory use only. Not for human or veterinary consumption. Nova Pharma sells to qualified researchers of legal age and ships to Canadian addresses only. See disclaimer and terms.
At a glance
At a glance
- Concentration
- 5mg
- Purity
- 99.5%+
- Route
- Subcutaneous injection
- Storage
- Lyophilized: room temperature, desiccated. Reconstituted: 2–8°C, ≤30 days.
Compound profile
TB-500 is a synthetic version of Thymosin Beta-4, a 43-amino-acid protein originally isolated from the thymus gland. Thymosin Beta-4 is one of the most abundant intracellular proteins and is expressed in virtually every tissue type, with particularly high concentrations in wound fluid, platelets, and cells undergoing migration. TB-500 replicates the active region of the full-length protein — specifically the actin-binding domain responsible for its regenerative properties — making it the research-optimized fragment of a naturally ubiquitous healing molecule.
TB-500 is a synthetic version of Thymosin Beta-4, a 43-amino-acid protein originally isolated from the thymus gland. Thymosin Beta-4 is one of the most abundant intracellular proteins and is expressed in virtually every tissue type, with particularly high concentrations in wound fluid, platelets, and cells undergoing migration. TB-500 replicates the active region of the full-length protein — specifically the actin-binding domain responsible for its regenerative properties — making it the research-optimized fragment of a naturally ubiquitous healing molecule.
TB-500 functions primarily through its interaction with actin, the structural protein that forms the cytoskeleton of every cell. By sequestering G-actin monomers and promoting their polymerization into F-actin filaments, TB-500 directly facilitates cell migration — the physical movement of cells into damaged tissue. This is the foundational mechanism of wound repair. Beyond cytoskeletal modulation, TB-500 promotes angiogenesis (new blood vessel formation) by upregulating vascular endothelial growth factor (VEGF), reduces inflammation through downregulation of pro-inflammatory cytokines including IL-1beta, TNF-alpha, and IL-6, and has demonstrated anti-fibrotic properties that may reduce scar tissue formation.
The research literature positions TB-500 as a systemic tissue repair agent. Unlike BPC-157, which acts preferentially at local injection sites, TB-500 distributes throughout the body after administration and exerts effects wherever tissue damage or inflammation exists. Studies have demonstrated accelerated healing in cardiac tissue following ischemic injury, improved dermal wound closure rates, reduced inflammation in musculoskeletal injuries, and enhanced recovery of damaged neural tissue. Researchers have also noted improvements in hair regrowth models, suggesting effects on dermal stem cell populations.
TB-500 is best suited for researchers investigating systemic recovery from musculoskeletal injuries, post-surgical healing, chronic inflammatory conditions, and cardiac tissue repair. It is the preferred companion to BPC-157 in healing stacks: TB-500 provides the broad, systemic regenerative signal while BPC-157 concentrates healing activity at the local level. This pairing is one of the most widely referenced combinations in the peptide research community.
Each 5mg vial should be reconstituted with 1-2ml bacteriostatic water. TB-500 has a notably long half-life of approximately 14 days, which allows for less frequent dosing compared to most peptides — typically twice-weekly subcutaneous injection. Researchers commonly use a loading phase of 5-10mg per week for the first 4-6 weeks, followed by a maintenance phase of 2-5mg per week. Reconstituted solution should be stored at 2-8C. TB-500 can be injected subcutaneously at any site; its systemic distribution means injection location is less critical than with site-specific compounds.
How to use
Injection technique, site rotation, and frequency guidance. Typical protocols split the weekly dose into 2 injections.
TB-500 5mg is supplied as a lyophilized (freeze-dried) powder and must be reconstituted with bacteriostatic water (BAC water) before use in a research setting.
- Clean the BAC water vial stopper and the peptide vial stopper with an alcohol swab. Allow to dry.
- Draw the required volume of BAC water into a sterile syringe (typically 1–3 mL depending on target concentration).
- Angle the needle so the water runs down the inside wall of the peptide vial. Avoid dispensing directly onto the powder.
- Do not shake. Gently swirl or roll until fully dissolved. Vigorous shaking can denature peptides.
- Refrigerate reconstituted solution at 2–8°C. Most reconstituted peptides are stable 14–30 days depending on compound.
Target concentration determines drawing volume. For dosing math, consult the dosing math guide.
Independent lab verification
Research disclaimer
For research and laboratory use only. Not for human or veterinary consumption. Nova Pharma sells to qualified researchers of legal age and ships to Canadian addresses only. See disclaimer and terms.
Read the research
Reference articles from the lab covering this compound.
beginner guides
Buy Peptides in Canada: Complete 2026 Buyer's Guide (What to Know First)
Complete 2026 guide to buying peptides in Canada. Legal status, vendor red flags, popular peptides (BPC-157, semaglutide, ipamorelin), storage, reconstitution, and what to look for in a Canadian source.
best of
Best Peptide Stacks 2026: Protocols That Work Together (By Goal)
Best peptide stacks for 2026 ranked by goal: fat loss, healing, anti-aging, muscle growth, sleep & cognition. Complete protocols with timing, dosing & duration.
best of
Best Peptides for Healing & Recovery 2026: Ranked by Injury Type
Discover the best peptides for healing ranked by injury type. BPC-157, TB-500, and targeted protocols for tendons, muscles, gut, joints, nerves, and post-surgery recovery in 2026.
Complete the protocol
Reconstitution Kit — Standard
30ml bac water · 10 syringes · mixing syringe · swabs
4.9
